Geron Announces November Investor Conference Presentation Webcasts
07 November 2016 - 11:30PM
Geron Corporation (Nasdaq:GERN) today announced that John A.
Scarlett, M.D., President and Chief Executive Officer, is scheduled
to present at the following investor conferences:
- Stifel 2016 Healthcare Conference in New York at 9:30 a.m. ET
on Tuesday, November 15, 2016.
- Piper Jaffray 28th Annual Healthcare Conference in New York at
12:30 p.m. ET on Wednesday, November 30, 2016.
A live audio webcast of each presentation will be available
through the Homepage and Investor Relations section of Geron’s
website under Events. Following the live presentations, the
webcasts will be archived and available for replay for a period of
30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on
the collaborative development of a first-in-class telomerase
inhibitor, imetelstat, in hematologic myeloid malignancies. For
more information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2024 to May 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From May 2023 to May 2024